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ABSTRACT
Objective: Emulgels as topical dosage form recently gains an interest represent a combination of gels and emulsions in united form. Metronidazole is 
an antimicrobial and anti-inflammatory drug, as the first topical therapy approved for rosacea; metronidazole has remained a cornerstone of rosacea 
management.
Methods: Emulgel formulations of metronidazole benzoate were prepared using two types of gelling agents, Carbopol 940 and hydroxypropyl 
methylcellulose, the influence of type and concentration of them on the release of metronidazole benzoate was investigated. The prepared formulations 
were evaluated on the basis of pH, spreadability, viscosity, drug content, in vitro release, and compatibility studies.
Results: All the prepared emulgels showed acceptable physical properties concerning color, homogeneity, consistency, spreadability, and pH value.
Conclusion: The best formulation (F4) prepared using Carbopol 940 as gelling agent showed the highest drug release through 5 h.
Keywords: Metronidazole benzoate, Emulgel, Carbopol 940, Hydroxypropyl methylcellulose.
INTRODUCTION
Topical drug administration is the simplest and easiest route of localized 
drug delivery anywhere in the body by routes as ophthalmic, rectal, 
vaginal, and skin [1]. Topical drug delivery systems are such system 
in which direct application of a formulation containing an active 
pharmaceutical ingredient to the skin to obtain the localizing effect of the 
drug [2]. Delivery of drugs to the skin is an effective and targeted therapy 
for local dermatological disorders. This route of drug delivery has gained 
popularity because it avoids first-pass effects, gastrointestinal irritation, 
and metabolic degradation associated with oral administration, drugs 
applied to the skin for their local action include antiseptics, antifungal 
agent, skin emollients, and protectants [3]. Emulgel is an emulsion, 
either of the oil in water or water in oil type, which is gelled by mixing 
with a gelling agent [4]. The main advantage of the emulgel that 
lipophilic drugs can be easily formulated as emulgels. Due to solubility 
problems, most of the lipophilic drugs cannot be formulated directly as 
a hydrogel. For this reason, emulgel provides better stability and release 
of the lipophilic drug in comparison with simple hydrogel base [5].
Metronidazole, which is a synthetic nitroimidazole derivative with 
antimicrobial and anti-inflammatory properties, has been reported 
to be effective in the treatment of rosacea through not only topical 
application but also systemic administration. As the first topical therapy 
approved for rosacea, metronidazole has remained a cornerstone of 
rosacea management.
Topical application of metronidazole was shown to be as effective as 
systemic antibiotic therapy. Metronidazole is particularly effective 
against papules and pustules and is a well-tolerated alternative to oral 
antibacterial. The exact mechanism by which topical metronidazole 
reduces inflammatory lesions and erythema in rosacea is unknown; it is 
suggested that its anti-inflammatory effect may be due to its antioxidant 
action [6]. Chemically metronidazole benzoate is 2-(2-methyl-5-nitro1H-
imidazole-1-yl) ethyl benzoate (Fig. 1), belonging to the category of the 
antiprotozoal drug [7].
The aim of this work was to develop an emulgel formulation of 
metronidazole benzoate using hydroxypropyl methylcellulose (HPMC) 
and Carbopol 940 as gelling agents. The influence of the gelling agent 
type and concentration was investigated. The rheological studies, 
spreading coefficient studies, pH, drug content, and in vitro drug release 
of the prepared emulgels were evaluated.
MATERIALS AND METHODS
Materials
Metronidazole benzoate was purchased from Lab Depot Inc., USA, HPMC, 
Carbopol 940 from HiMedia, India, liquid paraffin (Solvochem, UK). 
Spans 20 and Tween 20 were obtained from Merck Germany. All other 
chemicals were of analytical reagent grade.
Methods
Determination of λmax of metronidazole benzoate
Ultraviolet (UV)-Visible spectral analysis of metronidazole benzoate 
was done using a cary double beam UV-Visible spectrophotometer. 
Accurately weighed 50 mg of drug was dissolved in 10 ml of ethanol and 
transferred to 100 ml volumetric flask and the volume was completed 
with buffer pH 5.5 to form a stock solution 0.5 mg/ml. The absorbance 
was measured between the wave-length of 200 and 400 nm.
Calibration curve of metronidazole benzoate
Calibration curve of metronidazole benzoate in buffer pH 5.5 was 
obtained by preparing serial dilutions from a stock solution (0.5 mg/ml). 
Moreover, the samples were analyzed spectrophotometrically at their 
lambda maximum 319 nm. The absorbance of each sample was plotted 
versus concentrations.
Optimization of the concentration of emulsifying agent
The concentration of emulsifying agent and oil phase was optimized by 
performing a preliminary trial of an emulsion as in Table 1.
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i3.31504
Research Article
NOOR M DAOOD, ZAINAB E JASSIM*, MOWAFAQ M. GHAREEB AND HIBA ZEKI
572
Asian J Pharm Clin Res, Vol 12, Issue 3, 2019, 571-577
 Daood et al. 
Three different formulas of metronidazole benzoate emulsion were 
prepared using a different concentration of emulsifying agents, at a 
ratio (1:1), (1:1.66), and (3:1) of span 20 and tween 20, respectively. 
The selection of suitable emulsion depends on parameters such as 
appearance, phase separation, and oil globule formation at the time of 
emulsion formation. From considering these parameters, F3 containing 
emulsifying agent at a ratio (3:1) showed good oil globule formation, 
milkiness, and longer phase separation.
Preparation of metronidazole benzoate emulsion
The oil phase of the emulsion was prepared by dissolving span 20 in liquid 
paraffin while the aqueous phase was prepared by dissolving tween 20 in 
purified water. Methylparaben was dissolved in propylene glycol whereas 
drug was dissolved in methanol and both solutions mixed with the 
aqueous phase. Both the oily and aqueous phases were separately heated 
at 70–80°C, respectively, then the aqueous phase was added to the oily 
phase with continuous stirring until it got cooled to room temperature [8].
Preparation of metronidazole benzoate emulgel
The gel was prepared by dispersing Carbopol 940 in purified water with 
constant stirring and adjusted the pH to 6–6.5 using triethanolamine, 
HPMC was dispersed in purified water and kept overnight. The 
formulated emulsion was mixed with the gel in 1:1 ratio with gentle 
stirring to obtain the emulgel. The composition of different formulations 
has been demonstrated in Table 2.
Propylene glycol is added to the formulae as a humectant, to increase 
the spreadability; furthermore, it increases the esthetic benefits 
regarding of skin feel of the product.
Characterization of metronidazole benzoate Emulgel
Physical appearance
The prepared emulgel formulations were inspected visually for their 
color, homogeneity, consistency, grittiness, and phase separation [9].
Measurement of pH
The pH of emulgel formulations was determined using digital pH 
meter at room temperature (25±1°C) after 24 h without dilution. 
Measurements were taken in triplicates [10].
Rheology
The viscosity of the formulated batches was determined using a Myr 
VR 3000 viscometer with spindle 7, 6, and 5. The formulation whose 
viscosity was to be determined was placed in the beaker and was allowed 
to settle down for 30 min at room temperature before the measurement 
was taken. The spindle was lowered into the center of emulgel taking 
care that spindle did not touch the bottom of the beaker and rotated at 
a speed of 2, 2.5, 3, 4, 5, 6, 10, 12, 20, and 30 rpm. The viscosity reading 
was noted down and the averages of three readings were taken [11].
Determination of spreadability
A sample of (1 g) of each formula was pressed between two slides with 
500 g weight and left for about (5 min) where no more spreading was 
expected. Diameters of spread circles were measured in cm and were 
taken as comparative values for spreadability. The results obtained are 
the average of three determinations [12].
Determination of drug content in the emulgel formulas
Drug content in the emulgel was determined by taking 1 g of the prepared 
emulgel which is equivalent to 100 mg of metronidazole benzoate 
and transferred to 100 ml volumetric flask containing methanol then 
sonicated and filtered through a filter paper (0.45 μm, Millipore), then 
suitably diluted and analyzed using UV-visible spectrophotometer at 
λmax 319 nm using phosphate buffer (pH 5.5) as blank [13].
In vitro drug release studies
 A glass cup with a cross-sectional area of 7.5 cm2 was filled with 1 g of 
the emulgel, covered with a cellulose membrane, sealed with a rubber 
band, and inverted under the surface of 900 mL of phosphate buffer 
of pH 5.5 at 37±0.5°C in a United States Pharmacopeia dissolution 
tester with a paddle speed of 50 rpm. Aliquots were withdrawn at 
specified time intervals over 5 h period and immediately replaced 
with fresh dissolution medium. The drug content in the withdrawn 
samples was determined spectrophotometrically at 319 nm using a UV 
spectrophotometer (Cary, Australia) [14].
Fourier transforms infrared (FTIR) spectroscopy
The infrared spectra of metronidazole benzoate, Carbopol 940 and physical 
mixture of drug and Carbopol 940 (1:1) were recorded between 400 and 
4000 cm−1 to detect the drug-excipients interactions. The FTIR spectra 
for the test samples were obtained using KBr disk method using an FTIR 
spectrometer (Lambda scientific 7600, Australia). The resultant spectra 
were compared for any possible changes in the peaks of the spectra [15].
Differential scanning calorimetry (DSC)
Thermal analysis of metronidazole benzoate, Carbopol 940 and the 
physical mixture of drug and Carbopol 940 (1:1) was carried out using 
a Differential Scanning Calorimeter (Shimadzu DSC-60, Japan). Samples 
were placed in hermetically sealed aluminum pans. The temperature 
range tested was 25–300°C. Samples were heated at 10°C/min under a 
nitrogen atmosphere at a flow rate of 100 ml/min [16].
Photomicrography
Morphology of emulgel was studied under the light microscope. Optimized 
batches of the emulgel were viewed under a light microscope to study 
their shape. The emulgel was suitably diluted, mounted on a glass slide 
and viewed by the light microscope under magnification of ×10 [17].
Statistical analysis
The studies have been done in triplicate; the data represent the mean 
± standard deviation. The statistical analysis was performed using 
Fig. 1: Chemical structure of metronidazole benzoate
Table 1: Composition of metronidazole benzoate emulsion
Materials (g) F1 F2 F3
Drug 1 1 1
Liquid paraffin 5 5 5
Span 20 2 2.5 3
Tween 20 2 1.5 1
Propylene glycol 5 5 5
Methylparaben 0.15 0.15 0.15
water 36 36 36
Table 2: Composition of metronidazole benzoate emulgel
Materials (g) F1 F2 F3 F4 F5 F6
Drug 1 1 1 1 1 1
Liquid paraffin 5 5 5 5 5 5
Span 20 3 3 3 3 3 3
Tween 20 1 1 1 1 1 1
Propylene glycol 5 5 5 5 5 5
Methylparaben 0.15 0.15 0.15 0.15 0.15 0.15
HPMC 1 2 3
Carbopol 940 -- -- -- 0.5 1 1.5
Water up to 100 g q.s q.s q.s q.s q.s q.s
HPMC: Hydroxypropyl methylcellulose
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student’s t-test. A difference below the probability level was considered 
as statistically significant (p<0.05).
RESULTS AND DISCUSSION
Determination of λmax of metronidazole benzoate
Scanning of metronidazole benzoate stock solution (0.5 mg/ml) in 
phosphate buffer (pH 5.5) by UV spectrophotometer at 200–400 nm 
gave the spectrum shown in Fig. 2. The maximum absorbance (λmax) 
found to be 319 nm, which is similar to standard references [18].
Calibration curve of metronidazole benzoate
Fig. 3 shows the calibration curve of metronidazole benzoate in phosphate 
buffer (pH 5.5); a straight line was obtained by plotting the absorbance 
versus concentration. This indicates that the calibration curve within this 
range of concentration obeys Beer-Lamberts law at λmax 319 nm.
Physical appearance
Total six formulas of emulgel were prepared; emulgel formulations 
prepared with HPMC were off-white, while the formulations prepared 
using Carbopol 940 were white. All the formulas were viscous, 
creamy preparation with a smooth, homogeneous texture, and glossy 
appearance. Results have been discussed in Table 3.
Measurement of pH
The pH of the emulgel formulations was in the range of 5.4±0.015–
7.04±0.81 as shown in Table 3, which lies in the normal pH range of the 
skin and would not fabricate any skin irritation.
Rheology
Rheological behavior of the emulgel formulations exhibited non-
Newtonian shear thinning pseudoplastic type of flow, i.e., decreases 
in viscosity at increasing shear rates. As the shear stress is increased 
(Fig. 4), the disarranged molecules of the gelling material are caused to 
align their long axes in the direction of flow. Such orientation reduces 
the internal resistance of the material and decreases viscosity [19]. The 
viscosity of the formulations increases as the concentration of polymer 
increases; F3 that contain 3g of HPMC as the gelling agent did not show 
the readings on viscometer for the viscosity, and it might be due to the 
higher concentration of the gelling agent and high consistency.
F4 possessed thixotropic behavior, where the down curve was displaced 
about the up curve, showing at any rate of shear on the down curve 
lower shear stress than it had on the up curve; a hysteresis loop was 
formed between the two curves. Thixotropic, or time-dependent flow, 
occurs because the gel requires a finite time to rebuild its original 
structure that breaks down during continuous shear measurements. 
It is noteworthy that thixotropy is a desirable characteristic of 
pharmaceutical preparations, both in engineering design and consumer 
application, to deliver an initially thick product as a thinner, easily 
spreadable material.
The recorded viscosities of the different emulgel formulations at both 
low and high shear rates are shown in Fig. 4, which showed that the 
Carbopol-based formulations (F4, F5, and F6) possessed considerably 
higher viscosities than the HPMC-based formulations (F1and F2).
Spreadability
Spreadability of emulgel was measured regarding the diameter of a 
circle produced. Spreadability test was carried out for all the emulgel 
formulations as depicted in Fig. 5. The therapeutic efficacy of emulgel 
depends on its spread. The emulgel spreading helps in the uniform 
application to the skin, so the prepared formulas must have a good 
spreadability and satisfy the ideal quality in topical application. 
Furthermore, this is considered an important factor in patient 
compliance with treatment [20]. The diameters of the spread circles 
ranged from 6.9 cm seen with the emulgel prepared by Carbopol to 
8.9cm seen with HPMC emulgel. The spreadability of HPMC emulgel 
was more than Carbopol 940 emulgel and spreadability of the emulgel 
decreases with the increase in the concentration of the polymer.
Drug content determination
The drug content in emulgel was found in the range of 90±1–70±0.20%, 
the lower drug content it may be due to the high concentration of liquid 
paraffin and emulsifying agent [21], and the drug content of all emulgel 
formulation is given in Fig. 6.
In vitro drug release
The release of metronidazole benzoate from the prepared emulgels was 
performed to study the effect of polymers types, concentration and the 
effect of both emulsifying agent and oil phase on the release of drug 
aiming to select the best formula.
It was observed that all the formulations had become liquefied and 
diluted at the end of the experiment, indicating water diffusion through 
the membrane [22].
The in vitro release profile of metronidazole benzoate from its various 
emulgel formulations is depicted in Fig.7. In case of Carbopol 940 based 
formulations, the release of the drug can be ranked in the following 
descending order: F4 > F5 > F6, where the amounts of the drug release 
after 5 h were 9%, 6%, and 3%, respectively, while in the case of 
HPMC-based formulation the release of the drug can be ranked in the 
Fig. 2: Ultraviolet scan of metronidazole benzoate in phosphate 
buffer pH 5.5
Fig. 3: Calibration curve of metronidazole benzoate in phosphate 
buffer solution pH 5.5
Table 3: Physical characteristics of prepared metronidazole 
benzoate emulgel
Formula Color Homogeneity Phase separation pH*
F1 Off-white Excellent No 5.61±0.015
F2 Off-white Excellent No 5.56±0.09
F3 Off-white Excellent No 5.4±0.015
F4 White Excellent No 7.04±0.81
F5 White Excellent No 6.25±0.05
F6 White Excellent No 6.27±0.19
⃰Mean±SD, n=3. SD: Standard deviation 
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following descending order: F1 > F2, where the amounts of the drug 
release after 5h were 1% and 0.6 %, respectively. F3 containing 3% of 
HPMC was excluded from dissolution study due to its higher viscosity.
From these results, it can be concluded that Carbopol 940 based 
formulations show higher drug release (p<0.05) in comparison with 
corresponding HPMC-based formulations. The higher drug release was 
observed with Carbopol 940 based formulation F4.
Fig. 4: Rheograms of metronidazole benzoate emulgel formulations (mean±standard deviation, n=3)
Fig. 5: Spreadability of metronidazole benzoate emulgel 
(mean±standard deviation, n=3)
Fig. 6: Comparing of drug content of the various formulation of 
metronidazole benzoate emulgel (mean±standard deviation, n=3)
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The presence of liquid paraffin leads to retardation of drug release 
from its emulgel formulation. This finding was in agreement with 
El-Bary et al. [23], who proved that the presence of liquid paraffin lead 
to retardation of chloramphenicol release from its emulgel formulation.
FTIR spectroscopy
The infrared spectra of metronidazole benzoate, Carbopol 940 and 
physical mixture of drug and polymer were recorded and shown in 
Figs. 8-10, respectively.
FTIR spectra of metronidazole benzoate showed the characteristic bands 
at 1591 cm−1, 1583 cm−1, 1464.67 cm−1, 1451.10 cm−1, and 708.71 cm−1 
indicate the presence of the aromatic ring. The ester is characterized by 
the strong absorption band of the carbonyl C=O stretching vibration at 
1717.30 cm−1 and the control band of the C-O-single-bond vibrations 
at 1185.04 cm−1. The benzoate ester is characterized by the C-O-group 
bands at 1267.97 cm−1, 1259.83 cm−1, 1113.69 cm−1, and 1092.48 cm−1. 
The aromatic C-N-stretching vibrations are indicated by absorption 
bands at 1360.53 cm−1, and the aliphatic C-N-vibrations show bands 
at 1065.48 cm−1 and 1024.98 cm−1. The bands at 1523.49 cm−1 and 
1360.53 cm−1 indicate the presence of the nitro group [24].
Fig. 7: In vitro drug release profile from emulgel formulations 
(mean±standard deviation; n=3)
Fig. 8: Four ier transforms infrared spectrum of metronidazole benzoate
Fig. 9: Fourier transforms infrared spectrum of Carbopol 940
Fig. 10: Fourier transforms infrared spectrum of a physical mixture of drug and Carbopol 940 at a ratio (1:1)
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FTIR spectra showed that there were no interactions identified 
between drug and polymer. From the FTIR spectral analysis, all 
the principal peaks observed in pure drug were present in the 
FTIR spectra of the physical mixtures of best formulation since the 
absorption peaks of the drug still could be detected in the mixture as 
in Fig. 10.
DSC
Thermal analysis of metronidazole benzoate, Carbopol 940 and the 
physical mixture of drug and Carbopol 940 (1:1) was demonstrated in 
Figs. 11-13, respectively. The thermogram of crystalline metronidazole 
benzoate showed an endothermic sharp peak at 104°C due to the 
melting temperature of metronidazole benzoate which was consistent 
with literature value [25]. Carbopol 940 showed two endothermic peaks 
at 71°C and 239°C [26]. The physical mixture of drug and Carbopol 
940 at a ratio (1:1) showed the characteristic peak of metronidazole 
benzoate, indicating no interaction between drug and polymer.
Photomicrography
The suitably diluted emulgel of selected formula F4 was observed 
under the light microscope at ×10 (Fig. 14). From the photomicrograph, 
nearly spherical globules of emulsion were observed, though this study 
does not give any exact estimate of size; however, it gives a general idea 
about the formation of emulsion and success of the method used.
CONCLUSION
It can be concluded from the above results that metronidazole benzoate 
emulgel formulations prepared with Carbopol 940 (F4) showed 
acceptable physical properties, drug content, and drug release which 
deliver about 9% of drug within 5 h; thus, it can be suggested as a 
promising formula to prepare Metronidazole benzoate emulgel for the 
treatment of rosacea. However, further preclinical and clinical studies 
are required.
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